Nephrol Dial Transplant (2001) 16: 1382-1386
© 2001 European Renal Association-European Dialysis and Transplant Association
Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients
1 Department of Pediatrics, Umeå University Hospital, Umeå and 2 Department of Woman and Child Health, Karolinska Institute, Stockholm, Sweden
Background. Predictors of diabetic nephropathy are only partly known. The role of glomerular hyperfiltration is much discussed. We have studied the cumulative incidence of micro and macroalbuminuria and the predictive value of glomerular filtration rate (GFR) and screening value of albumin excretion rate (AER) in type-1 diabetes.
Methods. A cohort of diabetic children was followed up at a mean duration of 29±3 years. All 75 children treated in one hospital with diabetes duration 
8 years were prospectively followed for 8 years examining GFR, AER, blood pressure and HbA1c. After another 8–10 years, 60 of them were traced for endpoint follow-up.
Results. Seven patients (12%) developed macroalbuminuria, i.e. persistent overnight AER>200 mg/min, 12 (20%) developed persistent microalbuminuria (AER 15–200 mg/min) and 17 (28%) transient microalbuminuria (>15 mg/min on two consecutive occasions, normalized at endpoint). One baseline screening value of 24-h AER>15 mg/min predicted 93% of patients with persistent micro or macroalbuminuria. The negative predictive value was 78%. Six of seven macroalbuminuric and 10 of 12 microalbuminuric patients had a baseline GFR above the normal limit of the method (125 ml/min/1.73 m2). When adjusted for diabetes duration, increased GFR predicted macro or microalbuminuria (odds ratios=5.44, P=0.04). The positive predictive value for having an increased baseline GFR was 53%.The negative predictive value was 77%. Stratification for HbA1c did not change the effect of an increased GFR.
Conclusions. At a mean diabetes duration of 29 years the cumulative incidence of macroalbuminuria was 12%; however, another 20% had persistent microalbuminuria. A screening value of 24-h AER >15 mg/min was a strong predictor, whereas increased GFR was a weaker but significant predictor for micro and macroalbuminuria.
Keywords: albuminuria; cumulative incidence; glomerular filtration rate; type-1 diabetes
Correspondence and offprint requests to: Susanne Rudberg, MD, PhD, Astrid Lindgren Children's Hospital/Karolinska Hospital, S-171 76 Stockholm, Sweden.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. A. Perkins, L. H. Ficociello, B. E. Ostrander, K. H. Silva, J. Weinberg, J. H. Warram, and A. S. Krolewski Microalbuminuria and the Risk for Early Progressive Renal Function Decline in Type 1 Diabetes J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1353 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Zerbini, R. Bonfanti, F. Meschi, E. Bognetti, P. L. Paesano, L. Gianolli, M. Querques, A. Maestroni, G. Calori, A. Del Maschio, et al. Persistent Renal Hypertrophy and Faster Decline of Glomerular Filtration Rate Precede the Development of Microalbuminuria in Type 1 Diabetes Diabetes, September 1, 2006; 55(9): 2620 - 2625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Caramori, P. Fioretto, and M. Mauer Enhancing the Predictive Value of Urinary Albumin for Diabetic Nephropathy J. Am. Soc. Nephrol., February 1, 2006; 17(2): 339 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Yishak, T. Costacou, G. Virella, J. Zgibor, L. Fried, M. Walsh, R. W. Evans, M. Lopes-Virella, V. E. Kagan, J. Otvos, et al. Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohort Nephrol. Dial. Transplant., January 1, 2006; 21(1): 93 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Salcedo-Alejos, F. Banda-Espinoza, M. Rodriguez-Moran, and F. Guerrero-Romero Irbesartan reduces creatinine clearance in type 1 diabetic children with renal hyperfunction: a randomized, double-blind, placebo-controlled trial Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2120 - 2125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Steinke, A. R. Sinaiko, M. S. Kramer, S. Suissa, B. M. Chavers, M. Mauer, and for the International Diabetic Nephropathy Study G The Early Natural History of Nephropathy in Type 1 Diabetes: III. Predictors of 5-Year Urinary Albumin Excretion Rate Patterns in Initially Normoalbuminuric Patients Diabetes, July 1, 2005; 54(7): 2164 - 2171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Klein, B. Zinman, R. Gardiner, S. Suissa, S. M. Donnelly, A. R. Sinaiko, M. S. Kramer, P. Goodyer, S. E. Moss, T. Strand, et al. The Relationship of Diabetic Retinopathy to Preclinical Diabetic Glomerulopathy Lesions in Type 1 Diabetic Patients: The Renin-Angiotensin System Study Diabetes, February 1, 2005; 54(2): 527 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Gross, M. J. de Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz Diabetic Nephropathy: Diagnosis, Prevention, and Treatment Diabetes Care, January 1, 2005; 28(1): 164 - 176. [Abstract] [Full Text] [PDF]
|
|